Clearmind Medicine Inc. (CMND) KPIs and segments
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.62−0.33 (-6.67%)
Close on Nov 12, 2026Market cap $730.31KP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Clearmind Medicine's business
Coming soon
This tab will track the numbers specific to Clearmind Medicine's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?